Biocore® HSV-1/2 Quantity — a modern PCR test system for the detection and differentiation of herpes simplex virus types 1 and 2 (HSV-1, HSV-2) using real-time polymerase chain reaction (RT-PCR), developed by the Ukrainian company Biocore Technology. Registered name: ‘Biocore® HSV-1/2 Quantification’ diagnostic kit for the quantitative detection of human herpes simplex virus types 1 and 2 DNA by real-time PCR. Catalogue number: CM-HSV420-100
Biocore® HSV-1/2 PCR Kit (quantitative, herpes simplex virus types 1 and 2)
Intended use: Clinical in vitro diagnostics (IVD)
Number of reactions per pack: 100
TaqMan technology: The kit operates on the principle of TaqMan real-time PCR technology, which ensures high specificity and sensitivity of detection.
Endogenous quality control: The included internal control (IC) based on the human RNase P gene allows simultaneous monitoring of the DNA extraction stage, the correct progression of the reaction and the quality of the clinical sample collection.
Wide range of biomaterials: The biological materials suitable for DNA extraction include: whole blood, peripheral blood and umbilical cord blood samples, oropharyngeal swabs, saliva, cerebrospinal fluid (CSF), autopsy material, scrapings from the cervical canal and urethra, and urine.
The ‘Biocore® HSV-1/2 Quantity’ diagnostic kit enables the simultaneous detection of three targets:
HSV-1 DNA (herpes simplex virus type 1)
HSV-2 DNA (herpes simplex virus type 2)
endogenous control – the RNase P gene (IC – internal control), which is unique to humans
Technical specifications:
Validated for use on real-time PCR (RT-PCR) systems:
CFX96™ (Bio-Rad, USA)
CFX Opus 96™ (Bio-Rad, USA)
Rotor-Gene Q (Qiagen, Germany)
QuantStudio™ 5 (Applied Biosystems, USA)